Effects of aluminum on phosphate metabolism in rats: a possible interaction with vitamin D3 renal production.
The effect of chronic aluminum (Al) administration on the phosphorous (Pi) metabolism of different target tissues was studied. Male Wistar rats received aluminum lactate for 3 months (5.75 mg/kg bodyweight of Al, i.p., three times per week). The animals were studied at the end of the 1st, 2nd and 3rd month of treatment. They were housed individually in metabolic cages for 4 days to study Pi and calcium (Ca) balance. Daily food and water intakes were recorded for all animals and urine and feces were collected for Pi and calcium assays. After 3 months the Pi intestinal absorption and the Pi deposition in bone were studied using 32Pi. Another group of rats was treated daily for 7 days with calcitriol (0.08 microg/kg body weight in sesame oil, i.p.) and the Pi balance was studied for the last 4 days. The results indicated that chronic administration of Al affected simultaneously the Pi and calcium balance, with a significant diminution of calcium and increased Pi accretion in bones, together with a diminution in the intestinal absorption of Pi. The treatment of the rats with calcitriol promoted a normalized Pi balance in Al treated rats. These findings suggest that Al could modify the Pi metabolism acting directly on intestine, kidney and bone, or indirectly through possible changes in the levels of vitamin D3.
Mahieu
Stella T
ST
Fisiología Humana, Facultad de Bioquímica y Ciencias Biológicas, Universidad Nacional del Litoral, Paraje El Pozo, (3000) Santa Fe, Argentina.
Navoni
Julio
J
Millen
Néstor
N
del Carmen Contini
María
M
Gonzalez
Marcela
M
Elías
María Mónica
MM
D017607:Aluminum Compounds / Q000633:toxicity*; D000818:Animals; D002117:Calcitriol / Q000378:metabolism* / Q000494:pharmacology; D002118:Calcium / Q000378:metabolism; D005243:Feces / Q000737:chemistry; D005269:Femur / Q000187:drug effects / Q000378:metabolism; D007274:Injections, Intraperitoneal; D007408:Intestinal Absorption / Q000187:drug effects; D007583:Jejunum / Q000187:drug effects / Q000378:metabolism; D007668:Kidney / Q000378:metabolism*; D007773:Lactates / Q000633:toxicity*; D008297:Male; D010758:Phosphorus / Q000378:metabolism* / Q000652:urine; D010761:Phosphorus Radioisotopes; D051381:Rats; D017208:Rats, Wistar; D013977:Tibia / Q000187:drug effects / Q000378:metabolism
D017607:Aluminum Compounds; D007773:Lactates; D010761:Phosphorus Radioisotopes; D010758:Phosphorus; D002117:Calcitriol; D002118:Calcium; C104223:aluminum lactate